140 related articles for article (PubMed ID: 1560057)
21. [Genetics and cancers].
Maugard-Louboutin C
Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):929-38. PubMed ID: 1303491
[TBL] [Abstract][Full Text] [Related]
22. Congenital genetic instability in colorectal carcinomas.
Svendsen LB
Dan Med Bull; 1993 Nov; 40(5):546-56. PubMed ID: 8299399
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
24. [Genetic abnormalities in "sporadic" colorectal cancers].
Salmon RJ; Remvikos Y; Muleris M; Thomas G
Acta Gastroenterol Belg; 1991; 54(5-6):360-7. PubMed ID: 1803837
[No Abstract] [Full Text] [Related]
25. The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers.
Miyazaki M; Furuya T; Shiraki A; Sato T; Oga A; Sasaki K
Cancer Res; 1999 Oct; 59(20):5283-5. PubMed ID: 10537310
[TBL] [Abstract][Full Text] [Related]
26. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
27. Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer.
Remvikos Y; Gerbault-Seurreau M; Vielh P; Zafrani B; Magdelénat H; Dutrillaux B
Cytometry; 1988 Nov; 9(6):612-8. PubMed ID: 3208627
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of colorectal cancer from DNA level].
Shirasawa S; Yanagawa Y; Sasazuki T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):14-21. PubMed ID: 1846282
[TBL] [Abstract][Full Text] [Related]
29. [Flow cytogenetics. Principles, advantages and limitations. What trends for onco-hematology?].
Métézeau P
Pathol Biol (Paris); 1988 Jan; 36(1):46-51. PubMed ID: 3283671
[TBL] [Abstract][Full Text] [Related]
30. [Genetic abnormalities in colorectal cancer].
Salmon RJ; Girodet J; Remvikos Y; Muleris M; Olschwang S; Thomas G
Ann Gastroenterol Hepatol (Paris); 1995; 31(1):23-7. PubMed ID: 7710247
[No Abstract] [Full Text] [Related]
31. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
32. The genetics of colorectal cancer.
Bishop DT; Thomas HJ
Cancer Surv; 1990; 9(4):585-604. PubMed ID: 2101725
[TBL] [Abstract][Full Text] [Related]
33. Multiple genetic alterations in distal and proximal colorectal cancer.
Delattre O; Olschwang S; Law DJ; Melot T; Remvikos Y; Salmon RJ; Sastre X; Validire P; Feinberg AP; Thomas G
Lancet; 1989 Aug; 2(8659):353-6. PubMed ID: 2569552
[TBL] [Abstract][Full Text] [Related]
34. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
[TBL] [Abstract][Full Text] [Related]
35. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.
Sandberg AA; Berger CS
J Urol; 1994 Mar; 151(3):545-60. PubMed ID: 7905930
[No Abstract] [Full Text] [Related]
36. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis.
Williams AC; Browne SJ; Manning AM; Hague A; van der Stappen JW; Paraskeva C
Semin Cancer Biol; 1993 Jun; 4(3):153-9. PubMed ID: 8318691
[TBL] [Abstract][Full Text] [Related]
37. [Occurrence of numerical aberrations of chromosomes in metachronous liver metastases of colorectal cancers].
Kawai K; Ueda K; Ochiai T; Ogino A; Konishi E; Urata Y; Itoi H; Yamagishi H; Oka T; Ashihara T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():174-81. PubMed ID: 8678564
[TBL] [Abstract][Full Text] [Related]
38. Specific patterns of chromosomal abnormalities are associated with RER status in sporadic colorectal cancer.
Curtis LJ; Georgiades IB; White S; Bird CC; Harrison DJ; Wyllie AH
J Pathol; 2000 Dec; 192(4):440-5. PubMed ID: 11113860
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma: clinical significance of genetic abnormalities.
Brodeur GM
Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728
[TBL] [Abstract][Full Text] [Related]
40. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer.
Bauer KD; Bagwell CB; Giaretti W; Melamed M; Zarbo RJ; Witzig TE; Rabinovitch PS
Cytometry; 1993; 14(5):486-91. PubMed ID: 8354120
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
